These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4034239)
41. Biochemical and technical considerations regarding the mass production of certain parasitic protozoa. Enders B; Brauns F; Zwisler O Bull World Health Organ; 1977; 55(2-3):393-402. PubMed ID: 22407 [TBL] [Abstract][Full Text] [Related]
42. A novel non-amplification assay for the detection of Leishmania spp. in clinical samples using gold nanoparticles. Andreadou M; Liandris E; Gazouli M; Taka S; Antoniou M; Theodoropoulos G; Tachtsidis I; Goutas N; Vlachodimitropoulos D; Kasampalidis I; Ikonomopoulos J J Microbiol Methods; 2014 Jan; 96():56-61. PubMed ID: 24184015 [TBL] [Abstract][Full Text] [Related]
43. Increased calcium permeability is not responsible for the rapid lethal effects of amphotericin B on Leishmania sp. Cohen BE; Benaim G; Ruiz MC; Michelangeli F FEBS Lett; 1990 Jan; 259(2):286-8. PubMed ID: 2294016 [TBL] [Abstract][Full Text] [Related]
44. Control of yeast contamination with 5-fluorocytosine in the in vitro cultivation of Leishmania spp. Kimber CD; Evans DA; Robinson BL; Peters W Ann Trop Med Parasitol; 1981 Aug; 75(4):453-4. PubMed ID: 7030240 [No Abstract] [Full Text] [Related]
45. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559 [TBL] [Abstract][Full Text] [Related]
46. Detection of cutaneous Leishmania infection in paraffin-embedded skin biopsies using the polymerase chain reaction. Laskay T; Mikó TL; Negesse Y; Solbach W; Röllinghoff M; Frommel D Trans R Soc Trop Med Hyg; 1995; 89(3):273-5. PubMed ID: 7660431 [TBL] [Abstract][Full Text] [Related]
47. Synthesis and antileishmanial activity of lipidic amino alcohols. Coimbra ES; de Almeida MV; Júnior CO; Taveira AF; da Costa CF; de Almeida AC; Reis EF; da Silva AD Chem Biol Drug Des; 2010 Feb; 75(2):233-5. PubMed ID: 20028395 [TBL] [Abstract][Full Text] [Related]
48. Tegumentary leishmaniasis: a diagnostic approach considering aspects of the cytological examination. de Mello CX; de Morais LH; Schubach Ade O; Madeira F Acta Cytol; 2014; 58(4):383-7. PubMed ID: 25034702 [TBL] [Abstract][Full Text] [Related]
49. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period. Kucukates E; Erturan Z; Susever S; Yegenoglu Y APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609 [TBL] [Abstract][Full Text] [Related]
50. In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole. Rudramurthy SM; Jatana M; Singh R; Chakrabarti A Mycoses; 2013 Jan; 56(1):39-46. PubMed ID: 22519679 [TBL] [Abstract][Full Text] [Related]
51. Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana. Al-Mohammed HI; Chance ML; Bates PA Antimicrob Agents Chemother; 2005 Aug; 49(8):3274-80. PubMed ID: 16048936 [TBL] [Abstract][Full Text] [Related]
52. Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5'-(3'-phenylisoxazolino)methyl]-8-hydroxyquinoline: preliminary study. Dardari Z; Lemrani M; Bahloul A; Sebban A; Hassar M; Kitane S; Berrada M; Boudouma M Farmaco; 2004 Mar; 59(3):195-9. PubMed ID: 14987982 [TBL] [Abstract][Full Text] [Related]
53. A Plant like Cytochrome P450 Subfamily CYP710C1 Gene in Leishmania donovani Encodes Sterol C-22 Desaturase and its Over-expression Leads to Resistance to Amphotericin B. Bansal R; Sen SS; Muthuswami R; Madhubala R PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007260. PubMed ID: 30943203 [TBL] [Abstract][Full Text] [Related]
54. A simple procedure for the isolation of leishmanial parasites and for the recovery of parasite virulence in avirulent stocks. Grimaldi G; Jaffe CL; McMahon-Pratt D; Falqueto A Trans R Soc Trop Med Hyg; 1984; 78(4):560. PubMed ID: 6485065 [No Abstract] [Full Text] [Related]
55. [Growth of Leishmania mexicana and braziliensis in hemolytic and non-hemolytic media (preliminary report)]. Pérez-Martín O Rev Cubana Med Trop; 1983; 35(1):24-8. PubMed ID: 6351187 [No Abstract] [Full Text] [Related]
56. [Cultures on NNN medium for the diagnosis of leishmaniasis]. Chouihi E; Amri F; Bouslimi N; Siala E; Selmi K; Zallagua N; Ben Abdallah R; Bouratbine A; Aoun K Pathol Biol (Paris); 2009 May; 57(3):219-24. PubMed ID: 18456426 [TBL] [Abstract][Full Text] [Related]
58. Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P. Carrillo-Muñoz AJ; Ruesga M; Brio S; del Valle O; Rodriguez V; Santos P; Hernández-Molina JM; Cantón E; Pemán J; Guarro J; Quindós G Chemotherapy; 2002 Dec; 48(5):224-31. PubMed ID: 12476038 [TBL] [Abstract][Full Text] [Related]
59. Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress. Singh K; Ali V; Pratap Singh K; Gupta P; Suman SS; Ghosh AK; Bimal S; Pandey K; Das P Redox Biol; 2017 Aug; 12():350-366. PubMed ID: 28288415 [TBL] [Abstract][Full Text] [Related]
60. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients. Lombardi G; Gramegna G; Cavanna C; Michelone G Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]